Search

Travelers' Clinic
  Make a New Patient Appointment:  Call 202-741-2234 Make an Existing Patient Appointment Locations Providers   Services We Offer…
Kidney Disease & Hypertension
  Make a New Patient Appointment:  Call 202-741-2283 Current Patients: Log in to MyChart Locations Providers   Services We Offer…
Nicole Certner, PA-C, MPH
Nicole Certner is a certified Physician Assistant, within the Division of Hospital Medicine, at the George Washington University Hospital. Nicole received her Bachelor of Science in Kinesiology at the University of Maryland, College Park.
Deena Nasr, MHS, PA-C
Deena Nasr, MHS, PA-C, is a certified Physician Assistant in the Department of Orthopaedic Surgery as well as the Division of Hospital Medicine. She serves as Director of Advanced Practice Providers and Clinical Assistant Professor at the George Washington University Physician Assistant Program.
GW Anti-Reflux (GERD) Surgery
Gastroesophageal Reflux Disease (GERD) is a medical condition associated with acid reflux, heartburn, regurgitation, abdominal pain, coughing, bloating, and dysphagia (difficulty swallowing).
Jeremy Stillman, PA-C
Melissa Bucklin, PA-C
Melissa is a board certified physician assistant (PA). She is originally from Syracuse, NY. She attended the University of Rochester and obtained her bachelors in biology with a minor in epidemiology. During that time, she worked as a clinic research coordinator in the emergency department (ED).
Jose Lucar, MD
Jose Lucar, MD, is an infectious disease physician and associate professor of medicine in the Division of Infectious Diseases at the George Washington University (GW) School of Medicine and Health Sciences and the GW Medical Faculty Associates.
ICoN-1: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Efficacy and Safety of Clofazimine Inhalation Suspension When Added to Guideline-Based Therapy in Participants With Nontuberculous Mycobacterial Infection
ICoN-1 is a research study that evaluates the efficacy and safety of Clofazimine Inhalation Suspension on top of guideline-based therapy (GBT).
Novartis Multiple Patient Program for Lamprene (Clofazimine) for the Treatment of Non-Tuberculous Mycobacterial (NTM) Infections
Lamprene (Clofazimine) is approved by FDA for the treatment of leprosy. It is no longer available through pharmacies in the US. It is being tested in non-Novartis clinical studies for drug resistant tuberculosis and non-tuberculous mycobacteria (NTM).